Skip to content

177-lutetium-PSMA or Peptide Receptor Treatments

177-lutetium-PSMA in the treatment of metastatic prostate cancer

In January 2017, we were the first health care provider in Finland to use 177-lutetium-PSMA isotope therapy in the treatment of  advanced prostate cancer, which enables destroying metastases outside the bones efficiently without any severe adverse effects.

Before the treatment, we carry out a diagnostic PET scan using F-PSMA tracers to ensure that 177-lutetium-PSMA uptake occurs in the metastases.

177-lutetium-PSMA therapies are administered intravenously, and its their most common side effect is a dry mouth. Depending on the individual, the treatment is typically performed 2–6 times approximately every 4–6 weeks (177-lutetium-PSMA).

The multidisciplinary team in charge of peptide-receptor therapies at Docrates Cancer Center is led by Chief Physician in Nuclear Medicine Jukka Kemppainen.

The VISION study results* were presented in ESMO2021 conference: the results showed that treatment with 177-lutetium-PSMA significantly improved overall survival (OS) in patients with PSMA-positive metastatic castration-resistant prostate cancer.

*Publiced in NEJM September 2021

Read more

Patient story: Hannu Nurmio – Aiming for a normal everyday life

Hannu Nurmio was aware that prostate cancer is the most common cancer in older men. However, after the diagnosis was confirmed,...

Read more

The temporary technical problem in the data network connections has been corrected

A temporary technical problem occurred in the data network connections of Docrates Cancer Center has now been corrected. We apologise...

Early detection of colorectal cancer significantly improves treatment prognosis

Early detection of colorectal cancer is crucial for successful treatment. If diagnosed early, up to 90% of cancers can be...

Docrates is the first to launch a new type of alpha radiation therapy in the Nordic region

Docrates Cancer Center is the first service provider in the Nordic region to launch a new experimental alpha radiation treatment...

Why come to Docrates Cancer Center?

  • Top cancer experts and effective treatments without delay.
  • Individual care. You have your own care team - your doctor and your nurse.
  • Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
  • Experience in treating international patients from over 60 countries. Multilingual personnel.
+358 10 773 2010

Contact us!

Mon-Thu 8:00-18:00, Fri 8:00-16:00